Cargando…

Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3

Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Junyu, Kaleja, Patrick, Ückert, Larissa, Nezaratizadeh, Niloufar, Krantz, Stefanie, Krause, Martin Friedrich, Fitschen-Oestern, Stefanie, Seekamp, Andreas, Cassidy, Liam, Tholey, Andreas, Fuchs, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138495/
https://www.ncbi.nlm.nih.gov/pubmed/37108455
http://dx.doi.org/10.3390/ijms24087298
_version_ 1785032720328425472
author Xiong, Junyu
Kaleja, Patrick
Ückert, Larissa
Nezaratizadeh, Niloufar
Krantz, Stefanie
Krause, Martin Friedrich
Fitschen-Oestern, Stefanie
Seekamp, Andreas
Cassidy, Liam
Tholey, Andreas
Fuchs, Sabine
author_facet Xiong, Junyu
Kaleja, Patrick
Ückert, Larissa
Nezaratizadeh, Niloufar
Krantz, Stefanie
Krause, Martin Friedrich
Fitschen-Oestern, Stefanie
Seekamp, Andreas
Cassidy, Liam
Tholey, Andreas
Fuchs, Sabine
author_sort Xiong, Junyu
collection PubMed
description Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or pulmonary surfactant synthesis and guides epithelial defense during infection. In this study, we investigated the impact of VD(3) on the alveolar–capillary barrier in a co-culture model of alveolar epithelial cells and microvascular endothelial cells respectively in the individual cell types. After stimulation with bacterial LPS (lipopolysaccharide), gene expression of inflammatory cytokines, surfactant proteins, transport proteins, antimicrobial peptide, and doublecortin-like kinase 1 (DCLK1) were analyzed by real-time PCR, while corresponding proteins were evaluated by ELISA, immune-fluorescence, or Western blot. The effect of VD3 on the intracellular protein composition in H441 cells was analyzed by quantitative liquid chromatography-mass spectrometry-based proteomics. VD(3) effectively protected the alveolar–capillary barrier against LPS treatment, as indicated by TEER measurement and morphological assessment. VD(3) did not inhibit the IL-6 secretion by H441 and OEC but restricted the diffusion of IL-6 to the epithelial compartment. Further, VD(3) could significantly suppress the surfactant protein A expression induced in the co-culture system by LPS treatment. VD(3) induced high levels of the antimicrobial peptide LL-37, which counteracted effects by LPS and strengthened the barrier. Quantitative proteomics identified VD3-dependent protein abundance changes ranging from constitutional extracellular matrix components and surfactant-associated proteins to immune-regulatory molecules. DCLK1, as a newly described target molecule for VD(3), was prominently stimulated by VD(3) (10 nM) and seems to influence the alveolar–epithelial cell barrier and regeneration.
format Online
Article
Text
id pubmed-10138495
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101384952023-04-28 Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3 Xiong, Junyu Kaleja, Patrick Ückert, Larissa Nezaratizadeh, Niloufar Krantz, Stefanie Krause, Martin Friedrich Fitschen-Oestern, Stefanie Seekamp, Andreas Cassidy, Liam Tholey, Andreas Fuchs, Sabine Int J Mol Sci Article Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD(3) is known to stimulate lung maturity, alveolar type II cell differentiation, or pulmonary surfactant synthesis and guides epithelial defense during infection. In this study, we investigated the impact of VD(3) on the alveolar–capillary barrier in a co-culture model of alveolar epithelial cells and microvascular endothelial cells respectively in the individual cell types. After stimulation with bacterial LPS (lipopolysaccharide), gene expression of inflammatory cytokines, surfactant proteins, transport proteins, antimicrobial peptide, and doublecortin-like kinase 1 (DCLK1) were analyzed by real-time PCR, while corresponding proteins were evaluated by ELISA, immune-fluorescence, or Western blot. The effect of VD3 on the intracellular protein composition in H441 cells was analyzed by quantitative liquid chromatography-mass spectrometry-based proteomics. VD(3) effectively protected the alveolar–capillary barrier against LPS treatment, as indicated by TEER measurement and morphological assessment. VD(3) did not inhibit the IL-6 secretion by H441 and OEC but restricted the diffusion of IL-6 to the epithelial compartment. Further, VD(3) could significantly suppress the surfactant protein A expression induced in the co-culture system by LPS treatment. VD(3) induced high levels of the antimicrobial peptide LL-37, which counteracted effects by LPS and strengthened the barrier. Quantitative proteomics identified VD3-dependent protein abundance changes ranging from constitutional extracellular matrix components and surfactant-associated proteins to immune-regulatory molecules. DCLK1, as a newly described target molecule for VD(3), was prominently stimulated by VD(3) (10 nM) and seems to influence the alveolar–epithelial cell barrier and regeneration. MDPI 2023-04-14 /pmc/articles/PMC10138495/ /pubmed/37108455 http://dx.doi.org/10.3390/ijms24087298 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xiong, Junyu
Kaleja, Patrick
Ückert, Larissa
Nezaratizadeh, Niloufar
Krantz, Stefanie
Krause, Martin Friedrich
Fitschen-Oestern, Stefanie
Seekamp, Andreas
Cassidy, Liam
Tholey, Andreas
Fuchs, Sabine
Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title_full Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title_fullStr Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title_full_unstemmed Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title_short Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
title_sort alveolar–capillary barrier protection in vitro: lung cell type-specific effects and molecular mechanisms induced by 1α, 25-dihydroxyvitamin d3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138495/
https://www.ncbi.nlm.nih.gov/pubmed/37108455
http://dx.doi.org/10.3390/ijms24087298
work_keys_str_mv AT xiongjunyu alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT kalejapatrick alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT uckertlarissa alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT nezaratizadehniloufar alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT krantzstefanie alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT krausemartinfriedrich alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT fitschenoesternstefanie alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT seekampandreas alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT cassidyliam alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT tholeyandreas alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3
AT fuchssabine alveolarcapillarybarrierprotectioninvitrolungcelltypespecificeffectsandmolecularmechanismsinducedby1a25dihydroxyvitamind3